This independent RP-HPLC lab test confirms Retatrutide 36mg from Orbitrex Peptides at 99.928% purity. The analysis was conducted by Chromate on December 23, 2025.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its potential role in metabolic regulation, weight management, and glycemic control. A purity level of 99.928% indicates minimal contamination and high-grade synthesis.
Endotoxin testing confirmed < 0.0380 EU/mg, and heavy metal analysis showed < 100 ppb, demonstrating safety standards for research applications. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.